Showing all 2 results
Allergic Conjuctivitis (AC) | Landscape & Forecast | Competitive Landscape & Forecast, 2020-2030$5,250.00 – $15,750.00
The Allergic Conjuctivitis (AC) report provides the detailed overview of the disease and exhaustive understanding of historical and forecasted epidemiology. It highlights the prevailing treatment patterns, potential upcoming drugs and also identifies better of the market opportunities by providing the historical and forecasted market revenue, sales trends, and drug uptake during the study period from 2019-2030.
Wet Age-related Macular Degeneration (wAMD)| Primary Research (KOL’s Insight) | Competitive Intelligence | Market Analytics & Forecast 2030$6,500.00 – $19,500.00Growth of the Prevalence wet-AMD population specifically in the elderly population will contribute to increasing sales in the wet-AMD therapy market over our forecast period. According to WHO, by 2050, the world’s population aged 60 years and older is expected to total 2 billion. The rise in the number of the elderly population is a major key driver to develop more safe and effective treatment for wet AMD. Thus, a huge increase in the market size of wet AMD is expected in the coming years. An estimated annual growth rate of 4% in the Prevalent wet-AMD population across the major pharmaceutical markets will contribute to increasing wet-AMD therapy sales. In 2019, there were approximately xx million prevalent cases of wet-AMD in the major markets; we expect the number of cases will exceed xx million in 2030 owing to changes in population demographics and increasing aged population